SAREPTA THERAPEUTICS, INC. Class of Warrant or Right, Outstanding
SAREPTA THERAPEUTICS, INC. (SRPT) had Class of Warrant or Right, Outstanding of 0 shares as of 2014-12-31, per its 10-K filed 2015-02-26.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2015-02-26
- 2014-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2014-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2014-06-30: Class of Warrant or Right, Outstanding 501.49K shares.
- 2014-03-31: Class of Warrant or Right, Outstanding 633.74K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2014-12-31 | 0.00 shares 10-K · filed 2015-02-26 |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-06 |
| 2014-06-30 | 501.49K shares 10-Q · filed 2014-11-06 |
| 2014-03-31 | 633.74K shares 10-Q · filed 2014-08-07 |
| 2013-12-31 | 791.51K shares 10-K · filed 2015-02-26 |
| 2013-09-30 | 959.28K shares 10-Q · filed 2014-11-06 |
| 2013-07-03 | 2.63M shares 10-Q · filed 2014-11-06 |
| 2013-06-30 | 2.63M shares 10-Q · filed 2014-08-07 |
| 2013-03-31 | 3.09M shares 10-Q · filed 2014-08-07 |
| 2012-12-31 | 3.13M shares 10-K · filed 2015-02-26 |
| 2012-09-30 | 4.82M shares 10-Q · filed 2012-11-07 |
| 2012-06-30 | 4.87M shares 10-Q · filed 2012-08-07 |
| 2011-12-31 | 4.87M shares 10-K · filed 2015-02-26 |
| 2010-12-31 | 4.94M shares 10-K · filed 2014-03-03 |
| 2009-12-31 | 5.39M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |